Ethiopian News, Current Affairs and Opinion Forum
Zmeselo
Senior Member+
Posts: 37345
Joined: 30 Jul 2010, 20:43

China blocks entry to WHO team studying Covid's origins

Post by Zmeselo » 06 Jan 2021, 16:51



Coronavirus
China blocks entry to WHO team studying Covid's origins

Officials say visas not yet approved for World Health Organization delegation due to visit Wuhan


The World Health Organization’s director general, Tedros Adhanom Ghebreyesus

Sarah Boseley Health editor

https://www.theguardian.com/world/2021/ ... ds-origins

Tue 5 Jan 2021

China has blocked the arrival of a team from the World Health Organization investigating the origins of the coronavirus pandemic, https://www.theguardian.com/world/2020/ ... from-covid claiming that their visas had not yet been approved even as some members of the group were on their way.

The WHO’s director general, Tedros Adhanom Ghebreyesus, expressed his dismay and said he had called on China https://www.theguardian.com/world/china to allow the team in.
I’m very disappointed with this news, given that two members have already begun their journeys, and others were not able to travel at the last minute,
he said.
But I have been in contact with senior Chinese officials. And I have once again made made it clear that the mission is a priority for WHO and the international team.
The WHO has been attempting to send in the team of global experts from a number of countries for some months. It has been talking with Chinese officials since July. Scientists have long said it is essential to find out how the virus jumped species into humans.

________________________________________________________



Origin story: what do we know now about where coronavirus came from?
Read more... https://www.theguardian.com/world/2020/ ... from-covid

________________________________________________________

The expedition to China was heading to Wuhan to investigate the earliest cases. It was not intending to probe claims that the virus originated in a Chinese lab, which have been dismissed by most scientists. https://www.theguardian.com/world/2020/ ... ark-milley

The mission has been criticised by the US, where the outgoing president, Donald Trump, has categorically blamed the Chinese for the pandemic.

Garrett Grigsby, of the US Department of Health and Human Services, said in November the investigation appeared to be “inconsistent” with the WHO’s mandate.
Understanding the origins of Covid-19 through a transparent and inclusive investigation is what must be done to meet the mandate.
Dr Mike Ryan at WHO said the team had been working very closely with Chinese colleagues on planning the trip.
We were all operating on the understanding the team will begin deployment today [Tuesday],
he said.

Two members of the team, who had a long distance to travel, had begun their journeys, he said, but it had become clear that their visas had not been approved by the Chinese authorities.
We did not want to put people in the air unnecessarily if there wasn’t a guarantee of their arrival in China https://www.theguardian.com/world/china being successful,
said Ryan.
Dr Tedros has taken immediate action and has spoken with senior Chinese officials and has fully impressed upon them the absolute critical nature of this.
The team hoped it was
just a logistical and bureaucratic issue that can be resolved very quickly.
One of the two colleagues who were on their way had gone back, while the other was remaining in a third country in transit.
This is frustrating and, as the director general said, disappointing. That disappointment has been expressed very clearly by Dr Tedros directly to our counterparts in China. We trust that in good faith, we can solve these issues in the coming hours and recommence the deployment of the team as urgently as possible,
said Ryan.

Ilona Kickbusch, the founding director and chair of the Global Health Centre in Geneva, said geopolitics had got in the way of countries joining together to defeat the coronavirus pandemic and the hostilities that had been generated could now get in the way of finding out how it began.
I think it will be incredibly difficult to be able to find the origin of the virus, because so much time has passed,
Kickbusch said.

The world managed to come together to eradicate smallpox at the height of the cold war, she pointed out. Even when Sars, another coronavirus, surfaced in China and caused havoc between 2002 and 2003, the global reaction had been one of cooperation and a push for more transparency.

Back then, Beijing had acknowledged it had made mistakes, reorganised its health ministry and created the Chinese Center for Disease Control and Prevention. Other countries had given it the benefit of the doubt and called for more cooperation.
Sars actually led to China [understanding] that they needed to be much more integrated into the [global] system,
Kickbusch said.
It was a period of opening.
But now, she said:
There is a closing of the mind, quite clearly, on all sides.
Before the crisis, geopolitical tensions had bled into the global health response, she said, pointing to how the US-China trade war had morphed into a “geopolitical blame game”. As a result
China clamped down totally [and] the US did what it did
and in the end
the whole world has suffered.

Zmeselo
Senior Member+
Posts: 37345
Joined: 30 Jul 2010, 20:43

Re: China blocks entry to WHO team studying Covid's origins

Post by Zmeselo » 06 Jan 2021, 17:08



Biotech
Pfizer's CMO Rothenberg hits the exit, handing over the reins to Stanford's Habtezion

By Ben Adams

https://www.fiercebiotech.com/biotech/p ... -habtezion

Jan 5, 2021


Mace Rothenberg, M.D., is leaving Pfizer as chief medical officer. (Tracy Staton)

A new year and a new chief medical officer for Big Pharma Pfizer, as Mace Rothenberg, M.D., announced via Twitter that he’s off to pastures new, with Pfizer tapping Stanford University’s Aida Habtezion, M.D. as its new CMO.

Rothenberg leaves Pfizer after a major 12-year stint, working his way up through its oncology research division to become CMO in January 2019.

A year into this position and Pfizer became, alongside German partner BioNTech, one of the leading lights against the COVID-19 pandemic, with Rothenberg at the front. Last March, the Big Pharma tapped him to star in a series of short social media videos in the #KnowtheFacts about COVID-19 campaign, as hashtagged on Twitter.

This campaign featured Rothenberg offering levelheaded facts and personal tips for dealing with the COVID-19 outbreak. In the first video, he explains what the virus is, how it’s transmitted, what its symptoms are and who members of the high-risk populations are.

As well as being in front of the camera, he helped work behind the scenes on the development of the BioNTech-partnered vaccines, one of which has now been given emergency use grants by the U.S. and U.K. in recent weeks.

But now, as the rollout of that vaccine begins in earnest, Rothenberg was on Twitter again, but this time announcing his departure.
Today is my last day as Chief Medical Officer @pfizer. It has been an honor and privilege to serve in this role.
He did not say he was retiring, but gave no details of any new role he may be taking up in the future.


Aida Habtezion MD MSc. | Stanford Health Care

He will be succeeded by Aida Habtezion, https://medicine.stanford.edu/news/curr ... fizer.html a physician-scientist at Stanford University School of Medicine, who also spent six years as a clinical, integrative and molecular gastroenterology study section member at the National Institutes of Health.
I look forward to spending the next few months helping [Aida Habtezion] transition into the CMO role,
Rothenberg continued.
Aida is an extremely accomplished physician-scientist as well as an inspirational leader. I have every confidence in her continued success in this new role. Welcome to Pfizer, Aida!
She becomes Pfizer's new CMO as well as head of worldwide medical and safety within Worldwide Research, Development and Medicine, and will be one of very few female CMO leaders within the life science industry. The hiring also follows a new trend of tapping academia for top pharma R&D roles, with Roche/Genentech recently luring Aviv Regev, Ph.D., as its new head of research and early development from the Broad Institute.

Habtezion, who joined Stanford as an assistant professor a decade ago and also serves as faculty in the immunology doctoral program and at the Institute for Immunity, Transplantation and Infection, will
provide dynamic leadership and a strong medical voice for Pfizer as we transform into a purely innovative biopharmaceutical company,
according to the Big Pharma.

Post Reply